Cell Death-Inducing DFFA-Like Effector B (CIDEB) Antibody (Biotin)
169€ (20 µg)
Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.
935106861
info@markelab.com
name
Cell Death-Inducing DFFA-Like Effector B (CIDEB) Antibody (Biotin)
category
Primary Antibodies
provider
Abbexa
reference
abx316125
tested applications
ELISA
Description
CIDEB Antibody (Biotin) is a Rabbit Polyclonal against CIDEB conjugated to Biotin.
Documents del producto
Instrucciones
Data sheet
Product specifications
| Category | Primary Antibodies |
| Immunogen Target | Cell Death-Inducing DFFA-Like Effector B (CIDEB) |
| Host | Rabbit |
| Reactivity | Human |
| Recommended Dilution | Optimal dilutions/concentrations should be determined by the end user. |
| Clonality | Polyclonal |
| Conjugation | Biotin |
| Isotype | IgG |
| Purity | > 95% |
| Purification | Purified by Protein G. |
| Size 1 | 20 µg |
| Size 2 | 50 µg |
| Size 3 | 100 µg |
| Size 4 | 200 µg |
| Size 5 | 1 mg |
| Form | Liquid |
| Tested Applications | ELISA |
| Buffer | 0.01 M PBS, pH 7.4, 0.03% Proclin-300 and 50% Glycerol. |
| Availability | Shipped within 5-10 working days. |
| Storage | Aliquot and store at -20°C. Avoid exposure to light. Avoid repeated freeze/thaw cycles. |
| Dry Ice | No |
| UniProt ID | Q9UHD4 |
| Gene ID | 27141 |
| OMIM | 604441 |
| Alias | CIDEB, cell death-inducing DFFA-like effector b, cell death inducing DFFA like effector b,CIDE-B |
| Background | Antibody anti-CIDEB |
| Status | RUO |
Descripción
CIDEB is a protein critical for lipid metabolism and apoptosis, primarily expressed in the liver and associated with lipid droplet formation and triglyceride metabolism. It regulates lipid droplet growth and lipoprotein secretion, influencing hepatic lipid storage and export. CIDEB also participates in apoptosis by promoting the activation of caspase-dependent pathways, contributing to programmed cell death under stress conditions. Dysregulation of CIDEB has been implicated in liver diseases such as steatosis, non-alcoholic fatty liver disease (NAFLD), and liver fibrosis. Targeting CIDEB-mediated pathways is being explored for the treatment of metabolic liver diseases and conditions associated with altered lipid metabolism.
Related Products
Cell Death-Inducing DFFA-Like Effector B (CIDEB) Antibody
Rabbit polyclonal antibody against CIDEB protein. Immunogen region is Internal.
Ver Producto
Cell Death Activator CIDE-B (CIDE B) Antibody
Rabbit Polyclonal against the CIDE B protein.
Ver ProductoCell Death Activator CIDE-B (CIDE B) Antibody
Rabbit Polyclonal against the CIDE B protein.
Ver Producto